Coagulation Disorder
63
6
8
39
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.2%
2 terminated out of 63 trials
95.1%
+8.6% vs benchmark
8%
5 trials in Phase 3/4
5%
2 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (63)
SWIFT - SWIss Factor XIII Trial in PPH
Effects of Lipid Emulsions on Coagulation
Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
THrombo-Embolic Event in Onco-hematology
Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin
Coagulation in Acute Aortic Dissection
Impact of Renal Replacement Therapy on Coagulation Profile of Patients with Acute Renal Failure
The Utility of Thromboelastography in Traumatic Brain Injury
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Thrombelastography for Coagulopathy in Chinese Snakebites
Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant
Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes
Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.
Blood Coagulation Profile After Liver Resection.
Blood Loss and Preeclampsia
Bariatric Surgery on obesity-and Diabetes-associated Abnormalities of Hemostasis, Inflammation and Vascular Function.